Phase 1 Depression and Anxiety Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Men and women between the ages of 21 and 65
- People with a body weight considered in the healthy to moderately overweight range (BMI between 18 and 35)
- People willing to avoid taking any medications not approved by the study doctor during the trial
- People willing to avoid alcohol and recreational drugs during the trial
- People who return a negative drug test result
- People willing and able to avoid smoking during each test session
- Women who are able to become pregnant and are sexually active must be willing to use an effective form of contraception
- People willing to arrange transport to and from testing sessions rather than driving themselves
For people with Major Depressive Disorder (MDD), these additional criteria apply:
- People who have been diagnosed with Major Depressive Disorder
- People who have not had a satisfactory response to antidepressant medications
- People either currently receiving treatment for depression from a clinician and willing to continue that treatment throughout the study, or people not currently in treatment
- People willing to allow the research team to communicate with their mental health provider
- People whose mental health clinician supports their participation in the trial
For healthy volunteers, these additional criteria apply:
- People with no current psychiatric disorder (excluding nicotine or caffeine use)
- People who have not taken psychiatric medication for more than 3 months at any point in their life
Who may not be able to join:
- People taking medications that could significantly interfere with the study medications
- People with cognitive difficulties that could affect their ability to participate
- People with an alcohol or substance use disorder
- People with any history of a hallucinogen use disorder
- People who regularly use or have misused hallucinogens
- People with a history of bad reactions to drugs that alter perception
- People with significant blood pressure problems
- People who are pregnant or currently breastfeeding
- People with unstable medical conditions
- People with significant heart or cardiovascular disease
- People with significantly abnormal laboratory test results
- People with a history of serotonin syndrome (a serious reaction involving certain medications)
For people with MDD, these additional exclusions apply:
- People whose primary psychiatric diagnosis is something other than MDD
- People with a medical condition that would make participation unsuitable (confirm with trial site)
For healthy volunteers, these additional exclusions apply:
- People who currently have a psychiatric disorder (excluding nicotine or caffeine use)
- People with a close family history of serious mental illness such as schizophrenia or bipolar disorder
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Deepak D'Souza, MD, Yale University
Phone: (203) 932-5711
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Safety of Physiological indices; Psychedelic Effects; Psychotomimetic Effects; Anxiety; Depression; Intensity of the Experience; Drug Reinforcing Effects; Tolerability of Overt Adverse Effects; Electrophysiological
Can't join this trial?
Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.